Back to search

Article

Tumor-specific activity of precision medicines in the NCI-MATCH trial

2023-03-31

Abstract excerpt

<h4>Structured Abstract</h4> <h4>Background</h4> NCI-MATCH is a precision medicine basket trial designed to test the effectiveness of treating cancers based on specific genetic changes in patients’ tumors, regardless of cancer type. Multiple subprotocols have each tested different targeted therapies matched to specific genetic aberrations. Most subprotocols exhibited low rates of tumor shrinkage as evaluated acros...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
eea1bd3a-6534-5a3e-9156-474677c2dfbb
DOI
10.1101/2023.03.30.23287951
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Tumor-specific activity of precision medicines in the NCI-MATCH trialDOI 10.1101/2023.03.30.23287951
Tumor-Specific Activity of Precision Medicines in the NCI-MATCH Trial.Semantic proximity
Comparing the efficacy of cancer therapies between subgroups in basket trialsSemantic proximity
Umbrella review of basket trials testing a drug in tumors with actionable genetic biomarkersSemantic proximity
A state-of-the-art review of stratified medicine in cancer: towards a future precision medicine strategy in cancer.Semantic proximity
Revolutionizing cancer drug development: Harnessing the potential of basket trials.Semantic proximity
The NCI-MATCH: A National, Collaborative Precision Oncology Trial for Diverse Tumor Histologies.Semantic proximity
Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study.Semantic proximity
Redefining cancer: a new paradigm for better and faster treatment innovation.Semantic proximity
Evolving or Immutable - Phase I Solid Tumor Trials in the Era of Precision OncologySemantic proximity
National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network.Semantic proximity
Tumor-Type Agnostic, Targeted Therapies: BRAF Inhibitors Join the Group.Semantic proximity
An efficient basket trial design.Semantic proximity
Select a neighboring publication to make it the new centre.